Deutsche Bank Ag\ Astria Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$287 Billion
Q3 2025

A detailed history of Deutsche Bank Ag\ transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 33,339 shares of ATXS stock, worth $419,071. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,339

Previous 26,226 27.12%

Holding current value

$419,071

Previous $140,000 71.43%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$5.43 - $7.6 $38,623 - $54,058	7,113 Added 27.12%	33,339 $240,000
Q2 2025 Aug 12, 2025	SELL	$3.75 - $5.99 $34,151 - $54,550	-9,107 Reduced 25.77%	26,226 $140,000
Q1 2025 May 09, 2025	SELL	$5.34 - $9.1 $23,554 - $40,140	-4,411 Reduced 11.1%	35,333 $188,000
Q4 2024 Jun 30, 2025	BUY	$8.81 - $12.1 $38,860 - $53,373	4,411 Added 12.48%	39,744 $350,000
Q4 2024 Feb 14, 2025	BUY	$8.81 - $12.1 $123,216 - $169,230	13,986 Added 54.3%	39,744 $350,000

Q3 2024 Jun 26, 2025	SELL	$8.97 - $12.65 $85,887 - $121,123	-9,575 Reduced 27.1%	25,758 $283,000
Q3 2024 Nov 13, 2024	BUY	$8.97 - $12.65 $59,506 - $83,920	6,634 Added 34.69%	25,758 $283,000
Q2 2024 Jun 12, 2025	SELL	$8.83 - $13.51 $143,125 - $218,983	-16,209 Reduced 45.87%	19,124 $174,000
Q2 2024 Aug 14, 2024	SELL	$8.83 - $13.51 $44,962 - $68,792	-5,092 Reduced 21.03%	19,124 $174,000
Q1 2024 Jun 02, 2025	SELL	$6.99 - $16.69 $77,707 - $185,542	-11,117 Reduced 31.46%	24,216 $340,000
Q1 2024 May 15, 2024	BUY	$6.99 - $16.69 $53,103 - $126,793	7,597 Added 45.71%	24,216 $340,000
Q3 2023 Nov 09, 2023	BUY	$6.89 - $9.86 $23,577 - $33,740	3,422 Added 25.93%	16,619 $123,000
Q2 2023 Aug 14, 2023	BUY	$8.33 - $13.72 $109,931 - $181,062	13,197 New	13,197 $109,000

Others Institutions Holding ATXS

# of Institutions

121

Shares Held

50.8M

Call Options Held

48.8K

Put Options Held

55.8K

View Full List

About Astria Therapeutics, Inc.

Ticker ATXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,178,000
Market Cap $191M
Description
Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...

More about ATXS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account